![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 36, 33554-33560, September 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
with Members of the Forkhead Transcription Factor Family*
From the Department of Surgery and Molecular Pharmacology, Stanford
University School of Medicine, Stanford, California 94305
Estrogen acting through the estrogen receptor
(ER) is able to regulate cell growth and differentiation of a
variety of normal tissues and hormone-responsive tumors.
Ligand-activated ER binds DNA and transactivates the promoters of
estrogen target genes. In addition, ligand-activated ER can interact
with other factors to alter the physiology and growth of cells. Using a
yeast two-hybrid screen, we have identified an interaction between
ER
and the proapoptotic forkhead transcription factor FKHR.
The ER
-FKHR interaction depends on
-estradiol and is reduced
significantly in the absence of hormone or the presence of Tamoxifen. A
glutathione S-transferase pull-down assay was used to
confirm the interaction and localized two interaction sites, one in the
forkhead domain and a second in the carboxyl terminus. The FKHR
interaction was specific to ER
and was not detected with other
ligand-activated steroid receptors. The related family members, FKHRL1
and AFX, also bound to ER
in the presence of
-estradiol. FKHR
augmented ER
transactivation through an estrogen response
element. Conversely, ER
repressed FKHR-mediated transactivation
through an insulin response sequence, and cell cycle arrest induced by
FKHRL1 in MCF7 cells was abrogated by estradiol. These results suggest
a novel mechanism of estrogen action that involves regulation of the
proapoptotic forkhead transcription factors.
Supported by a George HA Clowes, MD, FACS, Memorial
Research Career Development Award through the American College of
Surgeons. To whom correspondence should be addressed: Medical School
Laboratory Surge Room P214, 1201 Welch Road, Stanford University School
of Medicine, Stanford, CA 94305; Tel.: 650-723-9799; Fax: 650-724-3229; E-mail: ronald. weigel{at}stanford.edu.
This article has been cited by other articles:
![]() |
Y. Kamei, S. Miura, T. Suganami, F. Akaike, S. Kanai, S. Sugita, A. Katsumata, H. Aburatani, T. G. Unterman, O. Ezaki, et al. Regulation of SREBP1c Gene Expression in Skeletal Muscle: Role of Retinoid X Receptor/Liver X Receptor and Forkhead-O1 Transcription Factor Endocrinology, May 1, 2008; 149(5): 2293 - 2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, M. J. Powell, V. M. Popov, and R. G. Pestell Acetylation in Nuclear Receptor Signaling and the Role of Sirtuins Mol. Endocrinol., March 1, 2008; 22(3): 539 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Papanicolaou, Y. Izumiya, and K. Walsh Forkhead Transcription Factors and Cardiovascular Biology Circ. Res., January 4, 2008; 102(1): 16 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D Rudd, I. Gonzalez-Robayna, I. Hernandez-Gonzalez, N. L Weigel, W. E Bingman III, and J. S Richards Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity J. Mol. Endocrinol., June 1, 2007; 38(6): 673 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paulmurugan and S. S. Gambhir An intramolecular folding sensor for imaging estrogen receptor-ligand interactions PNAS, October 24, 2006; 103(43): 15883 - 15888. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Buzzio, Z. Lu, C. D. Miller, T. G. Unterman, and J. J. Kim FOXO1A Differentially Regulates Genes of Decidualization Endocrinology, August 1, 2006; 147(8): 3870 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.J. Kim, O.L. Buzzio, S. Li, and Z. Lu Role of FOXO1A in the Regulation of Insulin-Like Growth Factor-Binding Protein-1 in Human Endometrial Cells: Interaction with Progesterone Receptor Biol Reprod, October 1, 2005; 73(4): 833 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Asselin-Labat, A. Biola-Vidamment, S. Kerbrat, M. Lombes, J. Bertoglio, and M. Pallardy FoxO3 Mediates Antagonistic Effects of Glucocorticoids and Interleukin-2 on Glucocorticoid-Induced Leucine Zipper Expression Mol. Endocrinol., July 1, 2005; 19(7): 1752 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Park, E. T. Maizels, Z. J. Feiger, H. Alam, C. A. Peters, T. K. Woodruff, T. G. Unterman, E. J. Lee, J. L. Jameson, and M. Hunzicker-Dunn Induction of Cyclin D2 in Rat Granulosa Cells Requires FSH-dependent Relief from FOXO1 Repression Coupled with Positive Signals from Smad J. Biol. Chem., March 11, 2005; 280(10): 9135 - 9148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Albers, H. Kranz, I. Kober, C. Kaiser, M. Klink, J. Suckow, R. Kern, and M. Koegl Automated Yeast Two-hybrid Screening for Nuclear Receptor-interacting Proteins Mol. Cell. Proteomics, February 1, 2005; 4(2): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pardee, J. Reinking, and H. Krause Nuclear Hormone Receptors, Metabolism, and Aging: What Goes Around Comes Around Sci. Aging Knowl. Environ., November 24, 2004; 2004(47): re8 - re8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guo and G. E. Sonenshein Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mol. Cell. Biol., October 1, 2004; 24(19): 8681 - 8690. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, H. Aburatani, et al. Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control J. Biol. Chem., September 24, 2004; 279(39): 41114 - 41123. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes Mol. Cell. Biol., September 15, 2004; 24(18): 7931 - 7940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Fox, P. Brown, C. Han, S. Ashe, R. D. Leek, A. L. Harris, and A. H. Banham Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor {alpha} and Improved Survival in Primary Human Breast Carcinomas Clin. Cancer Res., May 15, 2004; 10(10): 3521 - 3527. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, D. C. Muddiman, and D. J. Tindall Androgens Negatively Regulate Forkhead Transcription Factor FKHR (FOXO1) through a Proteolytic Mechanism in Prostate Cancer Cells J. Biol. Chem., April 2, 2004; 279(14): 13866 - 13877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Tomlinson and B. Damania The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Activates the Akt Signaling Pathway J. Virol., February 15, 2004; 78(4): 1918 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sunters, S. Fernandez de Mattos, M. Stahl, J. J. Brosens, G. Zoumpoulidou, C. A. Saunders, P. J. Coffer, R. H. Medema, R. C. Coombes, and E. W.-F. Lam FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines J. Biol. Chem., December 12, 2003; 278(50): 49795 - 49805. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Tsai, N. Bhattacharyya, L.-Y. Han, J. A. Hanover, and M. M. Rechler Insulin Inhibition of Transcription Stimulated by the Forkhead Protein Foxo1 Is Not Solely due to Nuclear Exclusion Endocrinology, December 1, 2003; 144(12): 5615 - 5622. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dowell, T. C. Otto, S. Adi, and M. D. Lane Convergence of Peroxisome Proliferator-activated Receptor {gamma} and Foxo1 Signaling Pathways J. Biol. Chem., November 14, 2003; 278(46): 45485 - 45491. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takahashi, T. Shintani, H. Sakuta, and M. Noda CBF1 controls the retinotectal topographical map along the anteroposterior axis through multiple mechanisms Development, November 1, 2003; 130(21): 5203 - 5215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, W.-Z. Chang, Y. Liu, and M. Centrella Runx2 Integrates Estrogen Activity in Osteoblasts J. Biol. Chem., October 31, 2003; 278(44): 43121 - 43129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuzaki, H. Daitoku, M. Hatta, K. Tanaka, and A. Fukamizu Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation PNAS, September 30, 2003; 100(20): 11285 - 11290. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. U. Birkenkamp and P. J. Coffer FOXO Transcription Factors as Regulators of Immune Homeostasis: Molecules to Die for? J. Immunol., August 15, 2003; 171(4): 1623 - 1629. [Full Text] [PDF] |
||||
![]() |
N. Gao, J. Zhang, M. A. Rao, T. C. Case, J. Mirosevich, Y. Wang, R. Jin, A. Gupta, P. S. Rennie, and R. J. Matusik The Role of Hepatocyte Nuclear Factor-3{alpha} (Forkhead Box A1) and Androgen Receptor in Transcriptional Regulation of Prostatic Genes Mol. Endocrinol., August 1, 2003; 17(8): 1484 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirota, H. Daitoku, H. Matsuzaki, N. Araya, K. Yamagata, S. Asada, T. Sugaya, and A. Fukamizu Hepatocyte Nuclear Factor-4 Is a Novel Downstream Target of Insulin via FKHR as a Signal-regulated Transcriptional Inhibitor J. Biol. Chem., April 4, 2003; 278(15): 13056 - 13060. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118. [Abstract] [Full Text] |
||||
![]() |
J. J. Kim, H. S. Taylor, G. E. Akbas, I. Foucher, A. Trembleau, R. C. Jaffe, A. T. Fazleabas, and T. G. Unterman Regulation of Insulin-Like Growth Factor Binding Protein-1 Promoter Activity by FKHR and HOXA10 in Primate Endometrial Cells Biol Reprod, January 1, 2003; 68(1): 24 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. McPherson, A. V. Loktev, and R. J. Weigel Tumor Suppressor Activity of AP2alpha Mediated through a Direct Interaction with p53 J. Biol. Chem., November 15, 2002; 277(47): 45028 - 45033. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hu, C.-R. Shyr, W. Che, X.-M. Mu, E. Kim, and C. Chang Suppression of Estrogen Receptor-mediated Transcription and Cell Growth by Interaction with TR2 Orphan Receptor J. Biol. Chem., September 6, 2002; 277(37): 33571 - 33579. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christian, X. Zhang, T. Schneider-Merck, T. G. Unterman, B. Gellersen, J. O. White, and J. J. Brosens Cyclic AMP-induced Forkhead Transcription Factor, FKHR, Cooperates with CCAAT/Enhancer-binding Protein beta in Differentiating Human Endometrial Stromal Cells J. Biol. Chem., May 31, 2002; 277(23): 20825 - 20832. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Conroy, M. Sharma, A. E. Holtz, C. Wu, Z. Sun, and R. J. Weigel A Novel Zinc Finger Transcription Factor with Two Isoforms That Are Differentially Repressed by Estrogen Receptor-alpha J. Biol. Chem., March 8, 2002; 277(11): 9326 - 9334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Richards, D. L. Russell, S. Ochsner, M. Hsieh, K. H. Doyle, A. E. Falender, Y. K. Lo, and S. C. Sharma Novel Signaling Pathways That Control Ovarian Follicular Development, Ovulation, and Luteinization Recent Prog. Horm. Res., January 1, 2002; 57(1): 195 - 220. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |